Our products

More than 2,500 topics covering disorders encountered in clinical practice, integrated into a single product for your computer or mobile.


Books

Printed volumes of common collections of topics, aggregated by clinical area. (Some book formats no longer available.)


Independent, reliable, respected

Therapeutic Guidelines is a leading source of independent, evidence-based, practical treatment advice to assist practitioners with decision making at the point-of-care.

Therapeutic Guidelines are regularly updated, based on the latest international literature, interpreted by Australia’s most respected experts, with input from an extensive network of general practitioners, pharmacists and other users.

October 2024 update
Therapeutic Guidelines is transitioning to a new technology platform to support more frequent content updates and modernise authentication processes. More information about the transition will be shared in the coming weeks.

A major content release is also right around the corner. Expect major updates to the Palliative Care, Rheumatology, and Toxicology and Toxinology guidelines, as well as more than 100 updates across other guidelines.

Independence is an essential feature of Therapeutic Guidelines. Funded only by subscribers, meaning no grants, advertising, shareholders or sponsors. To protect and maintain independence, a strict conflict of interest policy is in place.

Therapeutic Guidelines is an independent not-for-profit organisation. Its aim is to promote the quality use of medicines, which it does this through the development, publication and sale of Therapeutic Guidelines.

Latest newsTwitterLinkedin

New mobile app and digital platform coming soon!

In the coming weeks, customers will need to download a new mobile app from the Apple or Google Play Store.


New release: Australian Prescriber August issue

The issue highlights polycystic ovary syndrome, needlestick injuries and other blood or body fluid exposures in primary care, and more.


New Release: Australian Prescriber April Issue

The new release of Australian Prescriber covers biologic treatments for severe asthma, obstructive sleep apnoea management, the 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk, and more.